Accuray vs Inogen
Accuray is the larger business, with $402m of revenue in fiscal 2026 against $349m for Inogen (1.2 times as much). Inogen grew faster (3.9% against -12.3%). Inogen kept more of each dollar of sales as profit: a net margin of -6.5% against -12.2%. Inogen carries less debt relative to equity (0.0% against 436.4%).
| Latest fiscal year | AccurayARAY, 2026 | InogenINGN, 2025 |
|---|---|---|
| Revenue | $402m | $349m |
| Revenue growth | -12.3% | 3.9% |
| Net income | −$49.2m | −$22.7m |
| Operating margin | -6.6% | -8.7% |
| Net margin | -12.2% | -6.5% |
| Return on equity | -80.1% | -12.4% |
| Free cash flow | −$12.8m | −$13.7m |
| Cash | $40.6m | $104m |
| Total debt | $182m | $0 |
| Debt to equity | 436.4% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 809 | — |
| Market value | $17.3m | $186m |
| Price vs our value range | — | — |
| Moat score | 26 (Weak) | 41 (Weak) |
| Insider trades, 12 months | 4 buys, 0 sales | 0 buys, 2 sales |